TrialNeuro-oncology2026

Modern molecular profiling recontextualizes the NRG/RTOG 0539 trial and reveals hidden high-risk and radiotherapy-resistant meningiomas.

Leeor S Yefet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.